{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:55:05Z","timestamp":1793692505801,"version":"4.5.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACyT 20720190100005BA"],"award-info":[{"award-number":["UBACyT 20720190100005BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["PIDAE 2025-5181"],"award-info":[{"award-number":["PIDAE 2025-5181"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT START-UP 2020\u201300017"],"award-info":[{"award-number":["PICT START-UP 2020\u201300017"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2020-01571"],"award-info":[{"award-number":["PICT-2020-01571"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-025-02609-x","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:19:19Z","timestamp":1766755159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NO\/iNOS axis impact on glioma stem cells and temozolomide resistance"],"prefix":"10.1007","volume":"104","author":[{"given":"Elsa","family":"Hincapi\u00e9-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Moughty-Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Zaloff-Dakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Javier","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"G\u00f3mez-Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn Andr\u00e9s","family":"Merenzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Seoane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Jos\u00e9","family":"Recalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Socolovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Steven","family":"Zaninovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Solange","family":"Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Belgorosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-0194","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"Eij\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"8","key":"2609_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"key":"2609_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051236","author":"M Hassn Mesrati","year":"2020","unstructured":"Hassn Mesrati M, Behrooz AB, Abuhamad AY, Syahir A (2020) Understanding glioblastoma biomarkers: knocking a mountain with a hammer. Cells. https:\/\/doi.org\/10.3390\/cells9051236","journal-title":"Cells"},{"issue":"3","key":"2609_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF02761123","volume":"65","author":"MS Kannan","year":"1998","unstructured":"Kannan MS, Guiang S, Johnson DE (1998) Nitric oxide: biological role and clinical uses. Indian J Pediatr 65(3):333\u2013345","journal-title":"Indian J Pediatr"},{"issue":"1","key":"2609_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cell.2011.06.006","volume":"146","author":"CE Eyler","year":"2011","unstructured":"Eyler CE et al (2011) Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 146(1):53\u201366","journal-title":"Cell"},{"issue":"1","key":"2609_CR5","first-page":"165","volume":"62","author":"CV Rao","year":"2002","unstructured":"Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS (2002) Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62(1):165\u2013170","journal-title":"Cancer Res"},{"key":"2609_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216931","volume":"592","author":"T Chen","year":"2024","unstructured":"Chen T (2024) Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications. Cancer Lett 592:216931","journal-title":"Cancer Lett"},{"issue":"15","key":"2609_CR7","doi-asserted-by":"publisher","first-page":"25582","DOI":"10.18632\/oncotarget.16106","volume":"8","author":"P Palumbo","year":"2017","unstructured":"Palumbo P et al (2017) NOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression. Oncotarget 8(15):25582\u201325598","journal-title":"Oncotarget"},{"issue":"11","key":"2609_CR8","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00109-020-01973-0","volume":"98","author":"D Belgorosky","year":"2020","unstructured":"Belgorosky D et al (2020) Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model. J Mol Med 98(11):1615\u20131627","journal-title":"J Mol Med"},{"key":"2609_CR9","doi-asserted-by":"publisher","unstructured":"Rasouli M, Safari F, Kanani MH, Ahvati H (2024) \u201cPrinciples of hanging drop method (Spheroid Formation) in cell culture,\u201d 289\u2013300. https:\/\/doi.org\/10.1007\/7651_2024_527","DOI":"10.1007\/7651_2024_527"},{"issue":"1","key":"2609_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"L-B Weiswald","year":"2015","unstructured":"Weiswald L-B, Bellet D, Dangles-Marie V (2015) Spherical cancer models in tumor biology. Neoplasia 17(1):1\u201315","journal-title":"Neoplasia"},{"issue":"1\u20132","key":"2609_CR11","first-page":"70","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth GK (2009) ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347(1\u20132):70\u201378","journal-title":"J Immunol Methods"},{"issue":"3","key":"2609_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A et al (2017) Defining a cancer dependency map. Cell 170(3):564-576.e16","journal-title":"Cell"},{"issue":"6","key":"2609_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ et al (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38(6):675\u2013678","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2609_CR14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178(4):835-849.e21","journal-title":"Cell"},{"key":"2609_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.66","author":"OS Sahoo","year":"2024","unstructured":"Sahoo OS, Mitra R, Nagaiah NKH (2024) The hidden architects of glioblastoma multiforme: glioma stem cells. MedComm \u2013 Oncol. https:\/\/doi.org\/10.1002\/mog2.66","journal-title":"MedComm \u2013 Oncol"},{"issue":"2","key":"2609_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-025-00714-w","volume":"77","author":"S Bhuker","year":"2025","unstructured":"Bhuker S et al (2025) Genes and proteins expression profile of 2D vs 3D cancer models: a comparative analysis for better tumor insights. Cytotechnology 77(2):51","journal-title":"Cytotechnology"},{"issue":"3","key":"2609_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cas.13155","volume":"108","author":"T Ishiguro","year":"2017","unstructured":"Ishiguro T, Ohata H, Sato A, Yamawaki K, Enomoto T, Okamoto K (2017) Tumor-derived spheroids: relevance to cancer stem cells and clinical applications. Cancer Sci 108(3):283\u2013289","journal-title":"Cancer Sci"},{"issue":"6","key":"2609_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc1889","volume":"6","author":"AL Vescovi","year":"2006","unstructured":"Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6(6):425\u2013436","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2609_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/cas.12691","volume":"106","author":"J Neradil","year":"2015","unstructured":"Neradil J, Veselska R (2015) Nestin as a marker of cancer stem cells. Cancer Sci 106(7):803\u2013811","journal-title":"Cancer Sci"},{"key":"2609_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030497","author":"E Caballano-Infantes","year":"2022","unstructured":"Caballano-Infantes E, Cahuana GM, Bedoya FJ, Salguero-Aranda C, Tejedo JR (2022) The role of nitric oxide in stem cell biology. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11030497","journal-title":"Antioxidants"},{"issue":"6","key":"2609_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/cdd.2009.204","volume":"17","author":"S Mora-Castilla","year":"2010","unstructured":"Mora-Castilla S et al (2010) Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation. Cell Death Differ 17(6):1025\u20131033","journal-title":"Cell Death Differ"},{"key":"2609_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091408","author":"E Caballano-Infantes","year":"2021","unstructured":"Caballano-Infantes E et al (2021) Stemness of human pluripotent cells: hypoxia-like response induced by low nitric oxide. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10091408","journal-title":"Antioxidants"},{"issue":"1","key":"2609_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cell.2011.06.006","volume":"146","author":"CE Eyler","year":"2011","unstructured":"Eyler CE et al (2011) Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 146(1):53\u201366","journal-title":"Cell"},{"issue":"2","key":"2609_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2010.01.001","volume":"6","author":"N Charles","year":"2010","unstructured":"Charles N et al (2010) Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6(2):141\u2013152","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2609_CR25","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-22-2791","volume":"29","author":"TP Reddy","year":"2023","unstructured":"Reddy TP, Glynn SA, Billiar TR, Wink DA, Chang JC (2023) Targeting nitric oxide: say NO to metastasis. Clin Cancer Res 29(10):1855\u20131868","journal-title":"Clin Cancer Res"},{"key":"2609_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.niox.2023.06.002","volume":"138\u2013139","author":"MA Merenzon","year":"2023","unstructured":"Merenzon MA et al (2023) Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: a systematic review. Nitric Oxide 138\u2013139:10\u201316","journal-title":"Nitric Oxide"},{"issue":"4","key":"2609_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/cmdc.201900580","volume":"15","author":"C Maccallini","year":"2020","unstructured":"Maccallini C, Gallorini M, Cataldi A, Amoroso R (2020) Targeting iNOS as a valuable strategy for the therapy of glioma. ChemMedChem 15(4):339\u2013344","journal-title":"ChemMedChem"},{"issue":"26","key":"2609_CR28","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.1073\/pnas.91.26.12472","volume":"91","author":"C Szab\u00f3","year":"1994","unstructured":"Szab\u00f3 C, Southan GJ, Thiemermann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91(26):12472\u201312476","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2609_CR29","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/cas.12207","volume":"104","author":"R Kim","year":"2013","unstructured":"Kim R et al (2013) Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells. Cancer Sci 104(9):1172\u20131177","journal-title":"Cancer Sci"},{"issue":"8","key":"2609_CR30","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3174\/ajnr.A2170","volume":"31","author":"JR Wesolowski","year":"2010","unstructured":"Wesolowski JR, Rajdev P, Mukherji SK (2010) Temozolomide (Temodar). AJNR Am J Neuroradiol 31(8):1383\u20131384","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2609_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0527-x","volume":"17","author":"S Granados-Principal","year":"2015","unstructured":"Granados-Principal S et al (2015) Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Res 17(1):25","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2609_CR32","first-page":"17","volume":"4","author":"N Singh","year":"2021","unstructured":"Singh N, Miner A, Hennis L, Mittal S (2021) Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. Cancer Drug Resist 4(1):17\u201343","journal-title":"Cancer Drug Resist"},{"issue":"4","key":"2609_CR33","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1074\/jbc.M308197200","volume":"279","author":"K Kasuno","year":"2004","unstructured":"Kasuno K et al (2004) Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 279(4):2550\u20132558","journal-title":"J Biol Chem"},{"issue":"5","key":"2609_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"J-J Loh","year":"2024","unstructured":"Loh J-J, Ma S (2024) Hallmarks of cancer stemness. Cell Stem Cell 31(5):617\u2013639","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2609_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41374-020-00507-z","volume":"101","author":"LM L\u00f3pez-S\u00e1nchez","year":"2021","unstructured":"L\u00f3pez-S\u00e1nchez LM et al (2021) Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells. Lab Invest 101(3):292\u2013303","journal-title":"Lab Invest"},{"issue":"2","key":"2609_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/mmr.2013.1838","volume":"9","author":"J Dong","year":"2014","unstructured":"Dong J, Cheng M, Sun H (2014) Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor. Mol Med Rep 9(2):583\u2013589","journal-title":"Mol Med Rep"},{"issue":"1","key":"2609_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/cbin.11717","volume":"46","author":"ED Castro","year":"2022","unstructured":"Castro ED et al (2022) Knockdown of the inducible nitric oxide synthase (NOS2) splicing variant S3 promotes autophagic cell death from nitrosative stress in SW480 human colon cancer cells. Cell Biol Int 46(1):158\u2013169","journal-title":"Cell Biol Int"},{"issue":"11","key":"2609_CR38","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/carcin\/bgs241","volume":"33","author":"E McAdam","year":"2012","unstructured":"McAdam E et al (2012) Inducible nitric oxide synthase (iNOS) and nitric oxide (NO) are important mediators of reflux-induced cell signalling in esophageal cells. Carcinogenesis 33(11):2035\u20132043","journal-title":"Carcinogenesis"},{"issue":"25","key":"2609_CR39","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.3748\/wjg.v11.i25.3830","volume":"11","author":"G-Y Wang","year":"2005","unstructured":"Wang G-Y (2005) Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J Gastroenterol 11(25):3830","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2609_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/cancers11020231","volume":"11","author":"JM Fahey","year":"2019","unstructured":"Fahey JM, Girotti AW (2019) Nitric oxide antagonism to anti-glioblastoma photodynamic therapy: mitigation by inhibitors of nitric oxide generation. Cancers (Basel) 11(2):231","journal-title":"Cancers (Basel)"},{"issue":"31","key":"2609_CR41","doi-asserted-by":"publisher","first-page":"30831","DOI":"10.18632\/oncotarget.5036","volume":"6","author":"M-J Hsieh","year":"2015","unstructured":"Hsieh M-J, Lin C-W, Chiou H-L, Yang S-F, Chen M-K (2015) Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells. Oncotarget 6(31):30831\u201330849","journal-title":"Oncotarget"},{"key":"2609_CR42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2147\/CMAR.S433550","volume":"15","author":"S Liu","year":"2023","unstructured":"Liu S et al (2023) iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma [retraction]. Cancer Manag Res 15:809\u2013810","journal-title":"Cancer Manag Res"},{"issue":"39","key":"2609_CR43","doi-asserted-by":"publisher","first-page":"41863","DOI":"10.18632\/oncotarget.6172","volume":"6","author":"H Ito","year":"2015","unstructured":"Ito H, Ando T, Seishima M (2015) Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model. Oncotarget 6(39):41863\u201341874","journal-title":"Oncotarget"},{"issue":"6","key":"2609_CR44","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/1078-0432.CCR-09-3123","volume":"16","author":"AG Sikora","year":"2010","unstructured":"Sikora AG et al (2010) Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin Cancer Res 16(6):1834\u20131844","journal-title":"Clin Cancer Res"},{"issue":"20","key":"2609_CR45","doi-asserted-by":"publisher","first-page":"33047","DOI":"10.18632\/oncotarget.16523","volume":"8","author":"L Li","year":"2017","unstructured":"Li L et al (2017) iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer. Oncotarget 8(20):33047\u201333063","journal-title":"Oncotarget"},{"issue":"33","key":"2609_CR46","doi-asserted-by":"publisher","first-page":"52993","DOI":"10.18632\/oncotarget.10323","volume":"7","author":"J Wang","year":"2016","unstructured":"Wang J et al (2016) Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. Oncotarget 7(33):52993\u201353004","journal-title":"Oncotarget"},{"issue":"6","key":"2609_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/jgm.1045","volume":"9","author":"HO McCarthy","year":"2007","unstructured":"McCarthy HO, Coulter JA, Worthington J, Robson T, Hirst DG (2007) Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer. J Gene Med 9(6):511\u2013520","journal-title":"J Gene Med"},{"key":"2609_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj5070","author":"AW Chung","year":"2021","unstructured":"Chung AW et al (2021) A phase 1\/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.abj5070","journal-title":"Sci Transl Med"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02609-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02609-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02609-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T15:01:46Z","timestamp":1766761306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02609-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2609"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02609-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committees of Instituto de Oncolog\u00eda \u00c1ngel H. Roffo, Hospital de Cl\u00ednicas Jos\u00e9 de San Mart\u00edn and Hospital Jos\u00e9 Mar\u00eda Ramos Mej\u00eda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics spproval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\u00a0\n                      \n                      and Table\u00a0\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}